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Abstract
Deep learning has the potential to automate
echocardiogram analysis for early detection of
heart disease. Based on a qualitative analysis of
design concerns, this study suggests that predict-
ing normal heart function instead of disease ac-
counts for data quality bias and significantly in-
creases efficiency in cardiologists’ workflows.
1. Introduction
Cardiovascular diseases take the lives of 17.9 million peo-
ple every year, accounting for 31% of all global deaths
(WHO, 2017). Many consequences of heart disease could
be mitigated with early diagnosis. Echocardiograms are
ultrasound video scans of the heart that are non-invasive,
side-effect free, cheaper and faster to perform than other
imaging techniques. They are the most frequently used car-
diac imaging test for the screening, diagnosis, management,
and follow-up of patients with suspected or known heart
diseases. The left ventricle ejection fraction (LVEF) mea-
sures the percentage of blood leaving the heart each time it
contracts. It can be calculated from echocardiograms and
is used as a prognostic indicator to identify and follow the
progression of heart disease (Drazner, 2011).
Automating the analysis of echocardiogram scans is consid-
ered an important task for increasing access to health care
(Loh & Then, 2017), particularly for early disease detec-
tion in remote and low resource areas (Zhang et al., 2018).
Further benefits lie in improving the efficiency of medi-
cal care and for establishing effective public health pro-
grammes (Melero-Alegria et al., 2019). However, the mo-
tivation for the use of deep learning in echocardiogram
analysis is typically the potential to reduce human error
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and outperform human experts. Recent research has in-
deed shown that convolutional neural network models can
surpass human-level performance for estimating the LVEF
(Ouyang et al., 2020). Bizopoulos & Koutsouris (2019)
found that studies using deep learning for echocardiogra-
phy tended to be highly variable in terms of the research
questions that were asked, and inconsistent in the metrics
used to report results.
The goal of this study was to perform a qualitative anal-
ysis of the impact of automating echocardiogram analysis
at the Department of Cardiology at the Hospital Universi-
tario de Salamanca-IBSAL (HUSA) in Northern Spain. A
secondary objective was to build a pipeline for automated,
end-to-end echocardiogram analysis with deep learning for
HUSA. This paper discusses the design process and dis-
coveries, their impact on global health and on defining the
prediction goal for the pipeline, and the results achieved.
2. Design Process
Human-centred design offers a practical approach to ar-
riving at innovative design solutions. Methods from
IDEO.org’s Design Kit (IDEO) were used as practical tools
to analyze the potential impact of automating echocardio-
gram analysis with deep learning. At first, five guiding
questions were formulated during a brainstorming session:
1. What is the context for echocardiography at HUSA?
2. How is an echocardiogram study performed?
3. What is the role of the cardiologist in this process?
4. How are study results used for decision making?
5. Who is impacted by automating the analysis process?
Stakeholder mapping, testing assumptions with “5 Whys”,
mapping the journey of a cardiologist and performing a
conceptual analysis of deep learning for echocardiogram
analysis within a clinical setting were selected as appropri-
ate tools for arriving at answers to the guiding questions.
Qualitative information to answer these questions was gath-
ered over a series of video calls and a one-week site visit
to HUSA, which included participation in a routine clinic
visit to outlying rural areas, observing the process of tak-
ing echocardiogram scans of healthy, recovering and sick
patients, and participating in specialists’ morning meetings
where upcoming medical procedures and decisions are dis-
cussed.
3. Design Discoveries
Context The cardiology imaging unit at HUSA serves
over 40 patients per day and performs over 10,000 echocar-
diogram studies every year. 40% of the patients examined
at HUSA have normal heart function. Cardiologists also
perform echocardiogram studies during weekly visits to ru-
ral Spanish health centers to reduce the public transit bur-
den of patients that come for routine checkup or on refer-
ral from their physician. 80% of these patients require no
further intervention. If the study indicates abnormal heart
function, patients are referred to HUSA for further screen-
ings.
Echocardiogram Procedure During a study, the cardiol-
ogist captures different views of the heart from specific van-
tage points for several heartbeats on video. A typical study
takes 10 – 20 minutes. After performing the study, the
cardiologist analyses the video scans to calculate measure-
ments that indicate heart condition. To calculate LVEF, the
cardiologist selects the appropriate scan, identifies image
frames corresponding to one cardiac cycle’s end-systole
and end-diastole, and manually traces the heart chamber
in both frames. A software programme subsequently calcu-
lates the LVEF. The process is repeated and averaged over
5 heartbeats. A skilled specialist can annotate a study in 8
– 10 minutes, cumulating to 4 – 5 hours of annotations per
day.
Decision Making At HUSA, a LVEF of less than 40%
is considered abnormal, 40% to 60% grey zone, and above
60% normal. For patients with a normal LVEF and no med-
ical preconditions that put them at risk, deviation in the
LVEF is tolerable. Measurement deviations become a con-
cern when they are in the grey zone, especially when the pa-
tient’s medical history gives reason to suspect heart disease.
Patients at risk of heart disease will receive regular check-
ups, while serious cases will go for follow-up assessments
with more expensive equipment. Treatment decisions are
typically made by a multidisciplinary team of experts who
consider the health condition of the patient holistically.
Data Quality and Variability Echocardiogram studies
are guided by a standardized medical protocol. Nonethe-
less, variability exists in studies, making automated anal-
ysis more challenging than for other imaging modalities.
The specialist’s skill affects the scan quality. Occasionally
a scan is retaken due to quality issues, resulting in multiple
scans for the same view. The anatomy and health status of
the patient further affect data quality. The scans of older
and unhealthy patients, who are at greater risk of heart dis-
ease, are frequently of poorer quality due to rib protrusions,
obesity or movement during the procedure. Image quality
also varies across scanner models. HUSA employs multi-
ple different models simultaneously. Outlying clinics have
older models, which produce lower quality scans.
Implications of Discoveries Predictive results are ad-
versely affected by poor data quality. Variability in data
quality biases predictive accuracy against patients that are
more inclined to have a heart condition and that cannot ac-
cess newer scanner models. Leveraging this insight, by us-
ing automated analysis to filter out patients with normal
heart function, cardiologists can better allocate their time
and expertise. This could lead to positive downstream ef-
fects, such as focusing more attention on sick patients. In
addition, this could enable the public health system to in-
crease its capacity for routine checkups for early diagnosis.
4. Deep Learning Pipeline and Results
HUSA’s echocardiogram dataset consists of 25,000 anno-
tated studies collected over 10 years. Each study contains
video data in the DICOM format. Segmentation masks
and measurements were manually recorded by cardiolo-
gists and have been used to derive labels. Anonymized
patient metadata is available in a supplementary database.
Data cleaning, pre-processing and filtering was done to en-
sure consistent data representation and sampling.
The deep learning pipeline 1 replicates a cardiologist’s
process of analyzing an echogardiogram in three steps:
(1) classify views: parasternal long-axis, apical 2-chamber,
and apical 4-chamber; (2) segment chambers: left ventri-
cle and left atrium; (3) estimate measurement: LVEF. The
pipeline deploys the models of Zhang et al. (2018), using
a VGGNet (Simonyan & Zisserman, 2014) for classifica-
tion and U-net (Ronneberger et al., 2015) for segmentation.
The LVEF is then calculated from the segmentation masks.
Based on the design discoveries, the objective of the deep
learning pipeline is to identify patients with normal heart
function. Thus, when executed in sequence, the pipeline
predicts heart health to be normal, grey zone or abnormal.
Classification results had an accuracy of 98%. The segmen-
tation model DICE scores ranged from 0.83 – 0.88 depend-
ing on view and heart chamber. After estimating the LVEF,
the pipeline predicts normal heart condition with 80% pre-
cision and 30% sensitivity. High precision is necessary to
ensure that patients at risk receive care. Sensitivity indi-
cates the potential time saving for cardiologists.
5. Conclusion
Deep learning has the potential for automating echocardio-
gram analysis, the most frequently used imaging technique
for early detection of heart disease. While existing studies
focus on matching or surpassing experts’ ability to predict
disease, this paper suggests that predicting normal heart
1https://github.com/dssg/usal_echo_public
function instead aligns data quality with the prediction ob-
jective and significantly reduces cardiologists’ time invest-
ment in patients that do not need their expertise. This can
pave the way for large-scale, low-cost preventative heart
screenings, while reducing the time burden on skilled ex-
perts.
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